Authors:
Sieve, AN
King, TE
Ferguson, AR
Grau, JW
Meagher, MW
Citation: An. Sieve et al., Pain and negative affect: evidence the inverse benzodiazepine agonist DMCMinhibits pain and learning in rats, PSYCHOPHAR, 153(2), 2001, pp. 180-190
Authors:
King, TE
Tooze, JA
Schwarz, MI
Brown, KR
Cherniack, RM
Citation: Te. King et al., Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model, AM J R CRIT, 164(7), 2001, pp. 1171-1181
Authors:
King, TE
Schwarz, MI
Brown, K
Tooze, JA
Colby, TV
Waldron, JA
Flint, A
Thurlbeck, W
Cherniack, RM
Citation: Te. King et al., Idiopathic pulmonary fibrosis - Relationship between histopathologic features and mortality, AM J R CRIT, 164(6), 2001, pp. 1025-1032
Authors:
Hunninghake, GW
Zimmerman, MB
Schwartz, DA
King, TE
Lynch, J
Hegele, R
Waldron, J
Colby, T
Muller, N
Lynch, D
Galvin, J
Gross, B
Hogg, J
Toews, G
Helmers, R
Cooper, JAD
Baughman, R
Strange, C
Millard, M
Citation: Gw. Hunninghake et al., Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis, AM J R CRIT, 164(2), 2001, pp. 193-196
Authors:
Greene, KE
Kuroki, Y
Bartelson, BB
King, TE
Hunninghake, GW
Parsons, PE
Newman, LS
Nagoe, H
Tudor, R
Kuhn, C
Mason, RJ
Citation: Ke. Greene et al., Serum concentrations of surfactant proteins A and D predict mortality in patients with idiopathic pulmonary fibrosis, CHEST, 120(1), 2001, pp. 72S-72S
Citation: M. Selman et al., Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy, ANN INT MED, 134(2), 2001, pp. 136-151
Citation: Hr. Collard et Te. King, Treatment of idiopathic pulmonary fibrosis: The rise and fall of corticosteroids, AM J MED, 110(4), 2001, pp. 326-328
Citation: Ed. Crown et al., Shock-induced hyperalgesia: III. Role of the bed nucleus of the stria terminalis and amygdaloid nuclei, BEHAV NEURO, 114(3), 2000, pp. 561-573
Authors:
Dangas, G
Marmur, JD
King, TE
De Leon, J
Sharma, SK
Vidhun, R
Feldman, D
Stoynov, MY
Badimon, JJ
Ambrose, JA
Citation: G. Dangas et al., Effects of platelet glycoprotein IIb IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention, AM HEART J, 138(1), 1999, pp. 49-54
Citation: Rj. Panos et Te. King, Pathophysiology of interstitial lung disease, REHABILITATION OF THE PATIENT WITH RESPIRATORY DISEASE, 1999, pp. 115-135